Back to JANX
Prosight Management, LP → JANX
Prosight Management, LP JANX Position History
Janux Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$50.9M
Q3 2026
Peak value
$58.4M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $33M |
| Q1 2026 | $49.3M |
| Q2 2026 | $58.4M |
| Q3 2026 | $50.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $50.9M | 2.94M | — | — |
| Q2 2026 | $58.4M | 3.80M | — | — |
| Q1 2026 | $49.3M | 3.55M | — | — |
| Q4 2025 | $33M | 2.39M | — | — |
Other funds holding JANX
$345.1M
$264.1M
$242.9M
$218.5M
$193.4M
$171.9M
$171.5M
$156M